AKT1 and cancer: Of note, phosphatidylinositol-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling was found to enhance SCD1 expression as part of the mechanism of lipogenesis activation in cancer cells [48,49,52,53].